Search clinical trials for: FLT3 TKD
Total 168 results
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
Nanfang Hospital of Southern Medical UniversityRecruitingAcute Leukemia | Allogeneic Hematopoietic Stem Cell TransplantationChina
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationChina, Malaysia, Russian Federation, Singapore, Thailand
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFLT3 Gene Mutation Negative | FLT3 Internal Tandem Duplication Positive | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic...United States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | LeukemiaHong Kong, Canada, Belgium, France, Spain, Taiwan, United States, Australia, Czechia, Hungary, Italy, Israel, Japan, Korea, Republic of, Germany, China, Ukraine, Romania, Argentina, Croatia, Brazil, Serbia, Russian Federation, Portugal, Bulgari... and more
-
Akinion Pharmaceuticals ABTerminatedAcute Myeloid LeukemiaSweden, Poland, Czech Republic, United Kingdom
-
Technische Universität DresdenNovartis PharmaceuticalsCompletedAcute Myeloid LeukemiaGermany
-
Niguarda HospitalRecruitingCore Binding Factor Acute Myeloid Leukemia (CBF-AML)Italy
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Prof. Dr. Richard F SchlenkTerminatedAML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Recurrent Myeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Bayer; Genzyme, a Sanofi Company; Amgen; Georgia...CompletedLeukemia | Acute Myelogenous LeukemiaUnited States
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Icahn School of Medicine at Mount SinaiMerck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingNon-Hodgkin's Lymphoma | Metastatic Breast Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Uma BorateRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Acute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
Daiichi Sankyo, Inc.Children's Oncology Group; Innovative Therapies For Children with Cancer ConsortiumRecruitingAcute Myeloid LeukemiaUnited States, Spain, France, Israel, Denmark, Canada, Belgium, Italy, Netherlands, Sweden, United Kingdom
-
M.D. Anderson Cancer CenterGlaxoSmithKlineRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAcute Myeloid Leukemia (AML)China
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Kronos BioTerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States, Spain
-
Versailles HospitalActive, not recruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompleted
-
Centre Antoine LacassagneAcute Leukemia French AssociationNot yet recruiting
-
Curis, Inc.RecruitingMyelodysplastic Syndrome | Acute Myelogenous LeukemiaGermany, United States, Spain, Israel, Czechia, Poland, France, Italy
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic/Myeloproliferative Neoplasm | Refractory Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
PETHEMA FoundationDaiichi Sankyo, Inc.; Dynamic Science S.L.Active, not recruiting
-
Eilean TherapeuticsNot yet recruiting
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia | Mast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic Neoplasm | FMS-Like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia
-
National Cancer Institute (NCI)Not yet recruiting
-
Nantes University HospitalRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.Completed
-
Nantes University HospitalCentre de Recherche en cancérologie Nantes-Angers - CRCNACompleted